<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04746703</url>
  </required_header>
  <id_info>
    <org_study_id>APHP201020</org_study_id>
    <nct_id>NCT04746703</nct_id>
  </id_info>
  <brief_title>New Imaging Tools to Explore Impact of Bariatric Surgery on Pancreatic Lesions: PACHIBA- Bariatric Surg</brief_title>
  <acronym>PACHIBA</acronym>
  <official_title>New Imaging Tools to Explore Impact of Bariatric Surgery on Pancreatic Lesions: PACHIBA- Bariatric Surg</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose an exploratory study aiming at assessing the impact of surgical&#xD;
      bariatric treatment on the improvement of pancreatic lesions detected by MRI.&#xD;
&#xD;
      Pancreatic MRI will be performed in severe-obese patients with a planned bariatric surgery,&#xD;
      before and 6 months after bariatric surgery.&#xD;
&#xD;
      To assess the impact of bariatric surgery on pancreatic Magnetic Resonance Imaging (MRI)&#xD;
      parameters in severe-obese patients&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 10, 2021</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The investigators propose an exploratory study aiming at assessing the impact of surgical bariatric treatment on the improvement of pancreatic lesions detected by MRI.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantitative MRI parameters</measure>
    <time_frame>6 months after inclusion</time_frame>
    <description>Pancreatic fat content</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantitative MRI parameters</measure>
    <time_frame>6 months after inclusion</time_frame>
    <description>diffusion parameters (mm² / s)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantitative MRI parameters</measure>
    <time_frame>6 months after inclusion</time_frame>
    <description>transverse magnetization relaxation rate (Hz)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantitative MRI parameters</measure>
    <time_frame>6 months after inclusion</time_frame>
    <description>longitudinal relaxation rate (Hz)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantitative MRI parameters</measure>
    <time_frame>6 months after inclusion</time_frame>
    <description>visco-elastic parameters by measure of tissue stiffness (kPa)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metabolic and anthropometric parameters before and after bariatric surgery</measure>
    <time_frame>6 months after inclusion</time_frame>
    <description>BMI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic and anthropometric parameters before and after bariatric surgery</measure>
    <time_frame>6 months after inclusion</time_frame>
    <description>% fat mass in impedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic and anthropometric parameters before and after bariatric surgery</measure>
    <time_frame>6 months after inclusion</time_frame>
    <description>weight loss in percent of preoperative body weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic and anthropometric parameters before and after bariatric surgery</measure>
    <time_frame>6 months after inclusion</time_frame>
    <description>excess weight loss</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic and anthropometric parameters before and after bariatric surgery</measure>
    <time_frame>6 months after inclusion</time_frame>
    <description>blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic and anthropometric parameters before and after bariatric surgery</measure>
    <time_frame>6 months after inclusion</time_frame>
    <description>HOMA-IR index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lipids parameters</measure>
    <time_frame>6 months after inclusion</time_frame>
    <description>total cholesterol, HDL, LDL, triglycerides</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Bariatric Surgery</condition>
  <arm_group>
    <arm_group_label>MRI before and 6 months after bariatric surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Recruitment of patient with planned bariatric surgery in Louis Mourier Hospital by the nutritionist, during the preoperative day hospitalisation (performed during the multidisciplinary preparation for bariatric surgery) when patients are deemed eligible for bariatric surgery according to HAS (High Authority of Health) criteria.&#xD;
Programming of MRI in the month between preoperative visit and surgery. During this exam without injection of contrast agents in the radiology department of Louis Mourier Hospital, additional sequences with specific acquisitions as previously validated in humans will be performed for the study.&#xD;
Bariatric surgery will be performed as in usual care in Louis Mourier hospital. The same MRI will be performed in day hospitalization scheduled 6 months after surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Magnetic Resonance Imaging</intervention_name>
    <description>Pancreatic MRI will be performed in severe-obese patients with a planned bariatric surgery, before and 6 months after bariatric surgery.</description>
    <arm_group_label>MRI before and 6 months after bariatric surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults (aged 18 to 65 years) with a planned for bariatric surgery (sleeve gastrectomy)&#xD;
             according to HAS criteria&#xD;
&#xD;
          -  Patients with severe obesity (BMI≥35)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with problem of alcohol abuse (previous or current)&#xD;
&#xD;
          -  Patients with problems of understanding&#xD;
&#xD;
          -  Patients with previous acute or chronic pancreatitis&#xD;
&#xD;
          -  Patients with contraindication to MRI (active implantable medical devices, pacemaker,&#xD;
             claustrophobia …)&#xD;
&#xD;
          -  Inability to undergo MRI due to weight excess&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
&#xD;
          -  Absence of free and informed consent&#xD;
&#xD;
          -  Non affiliation to a social security regime or CMU (Universal health coverage)&#xD;
&#xD;
          -  Patient under AME (State medical aid)&#xD;
&#xD;
          -  Patient deprived of freedom, subject under a legal protective measure&#xD;
&#xD;
          -  Patients who have already had bariatric surgery&#xD;
&#xD;
        Secondary exclusion criteria :&#xD;
&#xD;
          -  Patients who have undergone bariatric surgery other than a sleeve gastrectomy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre d'obésité et de physiologie</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LEDOUX Severine</last_name>
      <phone>01 47 60 62 56</phone>
      <email>severine.ledoux@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>January 7, 2021</study_first_submitted>
  <study_first_submitted_qc>February 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bariatric surgery</keyword>
  <keyword>pancreatic parameters</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

